Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double-blind Study in Healthy Subjects.
Saved in:
| Title: | Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double-blind Study in Healthy Subjects. |
|---|---|
| Authors: | Chow V; Amgen Inc., Thousand Oaks, CA, USA., Mytych DT; Amgen Inc., Thousand Oaks, CA, USA., Das S; Amgen Inc., Thousand Oaks, CA, USA., Franklin J; Amgen Inc., Thousand Oaks, CA, USA. |
| Source: | Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Sep; Vol. 12 (9), pp. 863-873. Date of Electronic Publication: 2023 Jul 07. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
